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 2 
Abstract 22 
Immediately after birth, newborn babies experience rapid colonisation by microorganisms from their 23 
mothers and the surrounding environment1. Diseases in childhood and later in life are potentially mediated 24 
through perturbation of the infant gut microbiota colonisations2. However, the impact of modern clinical 25 
practices, such as caesarean section delivery and antibiotic usage, on the earliest stages of gut microbiota 26 
acquisition and development during the neonatal period (≤1 month) remains controversial3,4. Here we report 27 
disrupted maternal transmission of Bacteroides strains and high-level colonisation by healthcare-associated 28 
opportunistic pathogens, including Enterococcus, Enterobacter and Klebsiella species, in babies delivered 29 
by caesarean section (C-section), and to a lesser extent, in those delivered vaginally with maternal antibiotic 30 
prophylaxis or not breastfed during the neonatal period. Applying longitudinal sampling and whole-genome 31 
shotgun metagenomic analysis on 1,679 gut microbiotas of 772 full term, UK-hospital born babies and 32 
mothers, we demonstrate that the mode of delivery is a significant factor impacting gut microbiota 33 
composition during the neonatal period that persists into infancy (1 month - 1 year). Matched large-scale 34 
culturing and whole-genome sequencing (WGS) of over 800 bacterial strains cultured from these babies 35 
identified virulence factors and clinically relevant antimicrobial resistance (AMR) in opportunistic 36 
pathogens that may predispose to opportunistic infections. Our findings highlight the critical early roles of 37 
the local environment (i.e. mother and hospital) in establishing the gut microbiota in very early life, and 38 
identifies colonisation with AMR carrying, healthcare-associated opportunistic pathogens as a previously 39 
unappreciated risk factor.   40 
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Main 41 
The acquisition and development of the early-life gut microbiota follow successive waves of 42 
microbial exposures and colonisation that shapes the longer-term microbiota composition and function5. 43 
Early life events, including Caesarean section delivery1,6, formula feeding7,8 and antibiotic exposure8,9 that 44 
could perturb the gut microbiota composition are associated with the development of childhood asthma and 45 
atopy10-12. While recent studies8,9,13-15 have provided substantial insights into the gut microbiota 46 
development during the first 3 years of life, many were limited by the taxonomic resolution provided by 47 
16S rRNA gene profiling, small sample size or limited sampling during the first month of life (neonatal 48 
period). High-resolution metagenomic studies of large, longitudinal cohorts are required to establish the 49 
impact and risks of early life events on the gut microbiota assembly, particularly during the neonatal period 50 
where pioneering microbes could influence subsequent microbiota and immune system development16,17. 51 
To characterise the trajectory of gut microbiota acquisition and development during the neonatal 52 
period, we enrolled 596 healthy, term babies (39.5 ± 1.37 gestation weeks, 314 vaginal and 282 C-section 53 
births, Fig. 1a, Extended Data Table 1) through the Baby Biome Study (BBS). Faecal samples were 54 
collected from all babies at least once during their neonatal period (<1 month) with 302 babies re-sampled 55 
later in infancy (8.75 ± 1.98 months). Maternal faecal samples were also obtained from 175 mothers paired 56 
with 178 babies. Metagenomic analysis of 1,679 faecal samples from 772 babies and mothers revealed 57 
temporal dynamics of the gut microbiota development (Fig. 1b) and increased diversity with age (Extended 58 
Data Fig. 1a). Strikingly, the gut microbiotas exhibited substantial heterogeneity (inter-individual) and 59 
instability (intra-individual) during the first weeks of life (Extended Data Fig. 1b). Inter-individual 60 
differences explained 57% of the microbial taxonomic variation (Permutational multivariate analysis of 61 
variance (PERMANOVA), P < 0.001, 1,000 permutations), followed by sampling age at 5.7% of the 62 
variance (P < 0.001). These results indicate that the gut microbiotas were highly dynamic and 63 
individualised during the neonatal period, even more than observed in infancy (Extended Data Fig. 1c).  64 
To determine the impact of clinical covariates on the composition of the gut microbial community, 65 
we performed cross-sectional PERMANOVA, stratified by age. Mode of delivery was the most significant 66 
factor driving gut microbiota variation during the neonatal period (Fig. 2a, Supplementary Table 2), while 67 
other clinical covariates associated with hospital birth (e.g. perinatal antibiotics, duration of hospital stay) 68 
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and breastfeeding exhibited smaller effects (Supplementary Note 1). The largest effect of delivery mode 69 
was observed on day 4 (Fig. 2b, R2=7.64%, P<0.001), which dissipated with age but remained significant 70 
at the point of infancy sampling (R2=1.00%, P<0.01). No difference was observed in maternal gut 71 
microbiotas by delivery modes or neonatal gut microbiotas between elective and emergency C-section 72 
births (Supplementary Table 3).  73 
Given the significant effect of the mode of delivery during the neonatal period, we next sought to 74 
understand how the microbiota composition and developmental trajectory were altered. Samples from 75 
babies delivered vaginally were enriched with Bifidobacterium (e.g. B. longum, B. breve), Escherichia (E. 76 
coli) and Bacteroides/Parabacteroides species (e.g. B. vulgatus, P. distasonis) with these commensal 77 
genera comprising 68.3% (95% CI 65.7-71.0%) of the neonatal gut microbial communities (Fig. 2c, 78 
Supplementary Table 5), which validated the recent observations in other cohorts4,13. In contrast, the gut 79 
microbiota of C-section delivered babies were depleted of these commensal genera and instead were 80 
dominated by Enterococcus (E. faecalis, E. faecium), Staphylococcus epidermis, Streptococcus 81 
parasanguinis, Klebsiella (K. oxytoca, K. pneumoniae), Enterobacter cloacae and Clostridium perfringens, 82 
which are commonly associated with hospital environments18 and hospitalised preterm babies19-21. On day 83 
4, species belonging to these genera accounted for 68.25% (95% CI 62.74-73.75%) of the total microbiota 84 
composition in C-section delivered babies (Fig. 2c).  85 
Previous studies reported that, compared to C-section delivered babies, the gut microbiotas of 86 
vaginally delivered babies were enriched in lactobacilli associated with the mother’s vaginal microbiota1,22. 87 
However, here we observed no statistical difference in the prevalence (vaginal 11.9% vs C-section 15.7% 88 
present at over 1% abundance) or abundance of Lactobacillus between vaginally (1.217%, 95% CI 0.81-89 
1.621%) or C-section (2.21%, 95% CI 1.54-2.88%) delivered babies. Rather, commensal species from the 90 
Bacteroides genus were detected at high abundance in the gut microbiota of 49.0% (154/314) of vaginally 91 
delivered babies (mean relative abundance 8.13%, 95% CI 6.88-9.39%, Extended Data Fig. 3). In contrast, 92 
Bacteroides species were low or absent in 99.6% (281/282) C-section delivered babies (mean relative 93 
abundance 0.43%, 95% CI 0.11-0.74). In 60.6% (86/142) of the C-section babies, this low-Bacteroides 94 
profile (defined in Methods) persisted into infancy, when Bacteroides became the only differentially 95 
abundant species between vaginally and C-section delivered babies (Supplementary Table 5). Although we 96 
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could not assess the independent effect of maternal antibiotic exposure during C-section delivery as 97 
antibiotics were administered in all C-section deliveries, among vaginally delivered babies we observed a 98 
statistically significant association between the low-Bacteroides profile with maternal intrapartum 99 
antibiotic prophylaxis (IAP, OR=1.77, 95% CI: 1.17-2.71, P=0.0074), which also accounted for the greatest 100 
amount of gut microbiota variation in vaginally delivered babies (R2=5.88-13.6%, Supplementary Table 4). 101 
These results expand on previous findings9,23 and further highlight a low-Bacteroides profile as the 102 
perturbation signature associated with C-section and maternal IAP in vaginal delivery. 103 
Maternal transmission of gastrointestinal bacteria to their babies is an underappreciated form of 104 
kinship24. To assess if the neonatal microbiota variation could be attributed to differential transmission of 105 
maternal microbiota, we profiled the bacterial strain transmission across 178 mother-baby dyads. We show 106 
that the majority of maternal strain transmissions during the neonatal period occurred in vaginally delivered 107 
babies (74.39%), at much higher frequency in comparison with those delivered by C-section (12.56%, 108 
Fisher’s exact test, P<0.0001, Fig 3a, Extended Data Fig. 4, Supplementary Tables 6-7). Bacteroides spp., 109 
Parabacteroides spp., E. coli and Bifidobacterium spp. were most frequently transmitted from mothers to 110 
babies through vaginal birth, in agreement with previous observation in smaller cohorts4,25-27. For 111 
Bacteroides species such as B. vulgatus (Fig. 3b), the lack of transmission continued far beyond the neonatal 112 
period in C-section born babies25 with the late transmission of B. vulgatus rarely detected later in infancy. 113 
This is in contrast to the transmission pattern of other common early colonisers such as B. longum (Fig. 3c) 114 
and E. coli, for which colonisations of maternal strains occurred more frequently later in infancy (Fisher’s 115 
exact tests, P=0.0479 and P=0.0226, respectively). This result highlights the neonatal period as a critical 116 
early window of maternal transmission with the disrupted transmission of pioneering Bacteroides species 117 
evident in C-section babies with long-term Bacteroides absence.  118 
While C-section babies were deprived of maternally transmitted commensal bacteria, they had a 119 
substantially higher relative abundance of opportunistic pathogens commonly associated with the 120 
healthcare environment. These enriched species included E. faecalis, E. faecium, E. cloacae, K. 121 
pneumoniae, K. oxytoca and C. perfringens (Fig. 4a, Supplementary Table 5), some of which are members 122 
of the ESKAPE pathogens responsible for the majority of nosocomial infections28. Indeed, their frequent 123 
gut microbiota colonisation in C-section newborns was under-reported in previous smaller cohorts3,13 with 124 
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insufficient statistical power (Supplementary Note 2). Among C-section born babies, 83.7% carried 125 
opportunistic pathogen species during the neonatal period (as defined in Methods), in comparison to 49.4% 126 
of the vaginally born babies (Fig. 4a). During the first 21 days of life, these healthcare-associated 127 
opportunistic pathogens accounted for 30.4% (95% CI 27.86-32.96%) of the species level abundance in the 128 
gut microbiota of C-section babies, compared to 9.8% (95% CI 8.19-11.4%) in the vaginal babies, with the 129 
greatest difference observed on day 4 (Extended Data Fig. 5a). Longitudinally, the difference in combined 130 
opportunistic pathogen abundance persisted in the C-section babies re-sampled later in infancy (C-section 131 
2.8% versus vaginal 1.6%, P=0.0375, Welch’s t-test). Interestingly, frequent and abundant carriage of 132 
opportunistic pathogens were also observed in low-Bacteroides vaginally delivered babies (Extended Data 133 
Fig. 5b), while the absence of breastfeeding during the neonatal period was associated with a higher carriage 134 
of C. perfringens, K. oxytoca and E. faecalis (Supplementary Table 5).  135 
Given the prevalent carriage of opportunistic pathogens in the neonatal gut metagenomes, we sought 136 
to validate their presence and viability with culturing. We undertook targeted large-scale culturing of 836 137 
opportunistic pathogen strains in the faecal samples of 177 babies (70 vaginal and 107 C-section babies, 138 
total 741 isolates) and 38 mothers (95 isolates) using selective media (Fig. 4b, Supplementary Table 8). 139 
Subsequent WGS and genomic characterisation of E. faecalis (n=356), E. cloacae (n=52), K. oxytoca 140 
(n=150) and K. pneumoniae (n=78) allowed us to perform high-resolution phylogenetic analysis and to 141 
delineate strain-specific carriage of AMR genes and virulence factors. 142 
Focusing on the most prevalent opportunistic pathogen in C-section born babies, we analysed the 143 
genomes of a diverse population of BBS E. faecalis strains in the context of publicly available genomes of 144 
human and environmental strains (Fig. 4c). We found that 53.9% of the BBS strains were represented by 145 
five major lineages, each of which was distributed across vaginal and C-section babies and mothers in the 146 
three BBS hospitals (Extended Data Fig. 6a) and UK hospital patients, but did not include high-risk UK 147 
epidemic lineages enriched in multi-drug resistance (MDR) and virulence29. In congruence with the 148 
phylogenetic placement of the BBS strains with the human gastrointestinal and environmental strains, these 149 
non-epidemic E. faecalis exhibited comparable levels of carriage of AMR genes (Extended Data Fig. 6b, 150 
Supplementary Note 3). Similar to E. faecalis, the BBS Enterobacter and Klebsiella strains also exhibited 151 
high-level population diversities with the phylogenetic under-representation of epidemic lineages (Fig. 4d, 152 
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Extended Data Fig. 7), and levels of AMR and virulence gene carriage indicative of non-epidemic lineages 153 
circulating in hospital environments and healthy populations, rather than hypervirulent and ESBL-enriched 154 
epidemic lineages30-32 (Extended Data Fig. 8, Supplementary Note 3). Given the prior isolation of the major 155 
BBS lineages in hospitalised patients and their AMR and virulence capabilities, any level of opportunistic 156 
pathogen carriage represents a significant risk of future infections, especially for the C-section born babies 157 
with high prevalence (83.7%) of carriage.  158 
Whilst there is insufficient evidence from metagenomics and cultured isolate WGS that indicates 159 
an apparent maternal origin of the opportunistic pathogens (Supplementary Note 4), the absence of lineage-160 
specific colonisation suggests hospital environmental exposure as the primary factor driving opportunistic 161 
pathogen colonisation of the BBS babies. Although our study was not designed for retrospective sampling 162 
of the hospital environmental sources, opportunistic pathogens are frequently found in hospital 163 
environments, where hospital-born babies have been shown to carry the same bacteria present in operating 164 
rooms33 and neonatal intensive care units34. 165 
Undertaking the largest, longitudinal WGS characterisation of the human gut microbiota in the 166 
previously under-sampled neonatal period (≤1 month), we consolidate the recent findings that mode of 167 
delivery is a major factor shaping the gut microbiota in the first few weeks of life4, with the diminished 168 
effect persisting into infancy14,15. The disrupted transmission of the maternal gastrointestinal bacteria, 169 
particularly the pioneering Bacteroides species in birth via C-section and maternal IAP, predisposed 170 
newborn babies to colonisation by clinically important opportunistic pathogens circulating in healthcare 171 
and hospital environments. However, the clinical consequences of the early life microbiota perturbations 172 
and carriage of immunogenic pathogens during this critical window of immune development remain to be 173 
determined. This highlights the need for large-scale, long-term cohort studies that also sample home births35 174 
to better understand the consequence of hospital birth and establish if neonatal microbiota perturbation 175 
negatively impacts health outcomes in childhood and later life.   176 
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Figure legends 177 
Fig. 1: Developmental dynamics of the neonatal gut microbiota.  178 
a, Longitudinal metagenomic sampling of 1,679 early-life gut microbiotas of 772 individuals from 179 
three participating hospitals (A, B, C) of the Baby Biome Study. Each row corresponds to the time 180 
course of a subject, comprising 596 babies sampled during the neonatal period primarily on day 4 181 
(n=310), 7 (n=532) and 21 (n=325), in infancy (8.75 ± 1.98 months of age, n = 302), and from matched 182 
mothers (n = 175). b, Non-metric multidimensional scaling (NMDS) ordination of Bray–Curtis 183 
dissimilarity n = 917) between the species relative abundance profiles of the gut microbiota sampled 184 
from babies sampled on day 4, day 7, day 21, in infancy and from mothers (n = 175).  185 
Fig. 2: Perturbed neonatal gut microbiota composition and development associated with the 186 
mode of delivery  187 
a, Bar plot illustrating the clinical covariates associated with the neonatal gut microbiota variations on 188 
day 4 (n=310), day 7 (n=532), day 21 (n=325) and in infancy (n=302). Only the statistically 189 
significant associations in cross-sectional tests are shown. Covariates are ranked by the number 190 
statistically significant effect observed across sampling age groups. The proportion of explained 191 
variance (R2) and statistical significance were calculated using PERMANOVA on between-sample 192 
Bray-Curtis distances. b, Non-metric multidimensional scaling (NMDS) ordination of Bray–Curtis 193 
dissimilarity between the species relative abundance profiles of the gut microbiota sampled from 194 
babies on day 4 (vaginal delivery, n=157; C-section delivery, n=153), day 7 (vaginal delivery, n=280; 195 
C-section delivery, n=252), day 21 (vaginal delivery, n=147; C-section delivery, n=178), during 196 
infancy (vaginal delivery, n=160; C-section delivery, n = 142) and from mothers (vaginal delivery, 197 
n=110; C-section delivery, n=65). Microbial variation explained by the mode of delivery in each 198 
cross-section test is shown in the bottom left. All statistical tests were significant with PERMANOVA 199 
R2 and q-values reported in Supplementary Table 2. c, Longitudinal changes in the mean relative 200 
abundance (RA) of faecal bacteria at the genus level sampled on day 4, 7, 21 days of life and in 201 
infancy, for genera with > 1% RA across all neonatal period samples. Vaginal delivery, n=744 from 202 
310 babies; C-section delivery, n=725 from 281 babies.  203 
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Fig. 3: Disrupted maternal strain transmission in C-section-delivered babies. 204 
a, Early and late transmission of the maternal strains in mother-baby pairs (vaginal: 35, C-section: 24) 205 
longitudinally sampled during the neonatal (early) and infancy (late) period. Only the frequently 206 
shared species detected with sufficient coverage for strain analysis in more than 10 pairs are shown. 207 
Phylogenetically related species shared transmission pattern. b, c Transmission events of maternal B. 208 
vulgatus (b) and B. longum (c) strains in vaginally delivered, and C-section delivered babies over 209 
time. In each row of mother-baby paired samples, each circle represents a detectable strain either 210 
identical (filled) to or distinct from (hollow) the maternal strain. Across the rows, identical strains are 211 
linked by a solid line representing early transmission and persistence to infancy, while the dashed line 212 
indicates late transmission. 213 
Fig. 4: Extensive and frequent colonisation of C-section delivered babies with diverse 214 
opportunistic pathogen species previously associated with healthcare infection.  215 
a, The mean relative abundance (RA) and frequency (>1% RA) of six opportunistic pathogen species 216 
enriched C-section born babies (n=596), compared to vaginal-born babies (n=606) during the first 21 217 
days of life, in the context of the maternal level carriage (n=175). Error bars indicate the 95% CI of the 218 
mean relative abundance. Statistical significance of the differences in RA and frequency was determined 219 
by Holm’s-adjusted Wilcoxon and Fisher’s exact tests, respectively. ***P < 0.001, **P < 0.01, *P < 0.05 220 
b, Phylogenetic representation of 836 bacterial strains cultured from raw faecal samples, including six 221 
opportunistic pathogens isolated five major genera: Enterococcus spp. (red, n=451); Clostridium spp. 222 
(yellow, n=24); Klebsiella spp. (blue, n=235), Enterobacter spp. (green, n=52) and Escherichia spp. 223 
(purple, n=41). c, Phylogeny of the BBS E. faecalis isolates (n=282) in the context of public isolates 224 
from UK hospitals (n=168), the healthy human gut microbiotas (n=28) and environmental sources 225 
(n=27) with the high-risk UK epidemic lineage (CC2/CC28/CC388) branches coloured in blue. 226 
Midpoint-rooted maximum likelihood tree is based on SNPs in 1,656 core genes. d, Diverse 227 
Enterobacter-Klebsiella complex populations among the BBS collection (n=202), in the context of UK 228 
hospital (n=604), the healthy human gut microbiotas (n=37) and environmental sources (n=120).  229 
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Methods 230 
Study population  231 
The study was approved by the NHS London - City and East Research Ethics Committee (REC reference 232 
12/LO/1492). Participants were recruited at the Barking, Havering and Redbridge University Hospitals 233 
NHS Trust (BHR), the University Hospitals Leicester NHS Trust (LEI), and the University College London 234 
Hospitals NHS Foundation Trust (UCLH), through the Baby Biome Study (previously Life Study 235 
enhancement pilot study) from May 2014 to December 2017. Mothers provided written, informed consent 236 
to participate and for their children to participate in the study. 237 
Sample collection 238 
Faecal samples were collected from babies with at least one sample in the first 21 days of life, primarily on 239 
day 4, 7 or 21. For a subset of babies who provided neonatal samples, a follow-up faecal sample collection 240 
was performed between 4 to 12 months of their lives. Maternal faecal samples were collected in the 241 
maternity unit before or after delivery, or stool was collected during delivery by midwives. Baby samples 242 
were collected at home by mothers and returned to the processing laboratory by post at ambient temperature 243 
within 24 hours. On arrival at the lab, all faecal samples were immediately stored at 4°C for an average of 244 
2.41 days (95% CI 2.06-2.76 days) before further processing. Samples were aliquoted into six vials, four 245 
of which were stored at -80°C for raw faeces biobanking while the other two vials were processed 246 
immediately for DNA extraction. Although this sample storage protocol (no preservation buffer for room 247 
temperature and 4°C storage) was shown to be robust to technical variation in microbiome profiles at the 248 
time of study design (Supplementary Note 5), state-of-the-art sampling methods should be utilised in future 249 
large-scale microbiome to minimise the potential effect of sample storage on the microbiota composition36. 250 
DNA was extracted from 30 mg of faecal samples as described in the BBS collection and processing 251 
protocol37. Negative controls using ultrapure water was included in parallel for each kit as well as each 252 
extraction batch, and DNA concentration quantified to confirm contamination free. Total DNA was eluted 253 
in 60μl DNase/Pyrogen-free water, and stored at -80°C until shipment to the Wellcome Sanger Institute for 254 
metagenomic sequencing.  255 
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Shotgun metagenomic sequencing and analysis   256 
DNA samples, including negative controls, were quantified by PicoGreen dsDNA assay (Thermo Fisher), 257 
and samples with >100 ng DNA material proceeded to paired-end (2 x 125bp) metagenomics sequencing 258 
on the HiSeq 2500 v4 platform. Low-quality bases were trimmed (SLIDINGWINDOW:4:20), and reads 259 
below 87 nucleotides (70% of original read length) were removed (MINLEN:87) using Trimmomatic38. To 260 
remove potential human contaminants, quality trimmed reads were screened against the human genome 261 
(GRCh38) with Bowtie2 v2.3.039. On average, 22.4 (95% CI 22.1-22.6) million raw reads were generated 262 
per sample. 19.3 (95% CI 19.1-19.6) million reads (87.3% of the raw reads) per sample passed 263 
decontamination and quality trimming steps for downstream analysis. Sequencing depth was accounted for 264 
as a potential technical confounding factor in analyses of microbiota species and strain measurements, and 265 
significant species association with clinical covariates (Supplementary Note 6). Taxonomic classification 266 
from metagenomics reads was performed using Kraken v1.040, a k-mer based sequence classification 267 
approach against the Human Gastrointestinal Bacteria Genome Collection (HGG) genomes41. Bracken 268 
v1.042 was run on the Kraken classification output to estimate taxonomic abundance down to the species 269 
level. Metagenomic samples were compared at the genus and species levels by relative abundance. A cut-270 
off of 100 Kraken-assigned paired-end reads (corresponds to 0.001% relative abundance given the sampling 271 
depth of ~10 million paired-end reads) was applied to determine metagenomic species detection. To assess 272 
whether the trade-off between the observed level of Bacteroides and opportunistic pathogens was an 273 
artefact of compositional effects, the proportion of abundances and reads corresponding to Bacteroides 274 
were removed separately, prior to relative abundance normalisation. In the normalised datasets, the 275 
statistical enrichment of opportunistic pathogen species in C-section babies was consistent with the 276 
observation with the original data. The R packages phyloseq43  and microbiome44 was used for metagenomic 277 
data analysis and results visualised using ggplot245 in RStudio.   278 
Classification of the low-Bacteroides babies 279 
For each baby, the median relative abundance of the Bacteroides genus was calculated across the neonatal 280 
period samples. Based on the threshold described previously9, babies with a median abundance of less than 281 
0.1% were assigned low-Bacteroides status. 282 
  283 
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Classification of the opportunistic pathogen carriage 284 
Total opportunistic pathogen load is estimated by calculating the median relative abundance of combined 285 
opportunistic pathogen species (C. perfringens, E. cloacae, E. faecalis, E. faecium, K. oxytoca, K. 286 
pneumoniae) per individual across their neonatal period samples, and independently for the infancy period 287 
and maternal samples. To prioritise on relatively high-level opportunistic pathogen carriage feasible for 288 
downstream strain cultivation experiments, individuals with a median abundance of over 1% total 289 
opportunistic pathogen load were defined as a positive carriage.  290 
Maternal strain transmission analysis  291 
Strain transmissions in mother-baby paired samples were determined using a single-nucleotide variant 292 
calling method46. StrainPhlAn was run on pre-processed metagenomes to generate consensus species-293 
specific marker genes for phylogenetic reconstruction of all detectable strains (one dominant strain per 294 
sample), using default parameters and with the options "--alignment_program mafft" and "--295 
relaxed_parameters3" as previously described26. No statistically significant variation in sequencing depth 296 
was observed between vaginal and C-section born subjects across age groups that had any impact on 297 
coverage-dependent microbiota species and strains detection (Supplementary Note 6). For each species and 298 
strains with sufficient coverage for strain profiling, we generated a species-specific phylogenetic tree using 299 
RAxML47. As previously described26, the strain distance for each pair of mother-baby sample strains was 300 
computed by calculating the pairwise normalised phylogenetic distance on the corresponding species tree.  301 
To define strain transmission events,  a previously described26, conservative threshold of 0.1 on the strain 302 
distance value was used. The detectable strains in a given pair of mother-baby samples were considered 303 
identical (strain distance less than 0.1, transmission) or distinct (strain distance greater than 0.1, no 304 
transmission). For all mother-baby pairs shown in Extended Data Fig. 4, early transmission event was 305 
counted once per species per mother-baby pair, considering the detected transmission (or evidence for no 306 
transmission) at the earliest time point (primary transmission), irrespective of the subsequent transmission 307 
events in any later neonatal period samples. For a subset of mother-baby pairs with both neonatal and 308 
infancy period sampled (shown in Fig. 3a), late transmission events were counted separately, including 309 
cases of no early transmission due to insufficient coverage (no detectable strains). To highlight the 310 
transmission pattern shared by phylogenetically related species, a neighbour-joining tree of the eligible 311 
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species was constructed based on the mash distance matrix49 of the respective reference genomes 312 
included in the StrainPhlAn database (Supplementary Table 9). The same approach and strain distance 313 
threshold (core-genome SNPs) were applied to the cultured strains to count the number of identical and 314 
distinct strains within mother-baby and longitudinal paired samples.   315 
Statistical analysis 316 
To calculate the effect of clinical covariates on the gut microbiota composition, we stratified by age groups 317 
and then assessed the proportion of explained variance (R2 from PERMANOVA) in Bray-Curtis distance 318 
for each clinical covariate, using the adonis from the R package vegan50. While PERMANOVA is mostly 319 
unaffected by group dispersion effects in balanced designs51 (e.g. mode of delivery comparisons), for 320 
unbalanced designs (e.g. breastfeeding comparisons) more sensitive to group dispersion effects, the group 321 
variance homogeneity condition was validated using the betadisper function. Group dispersions were not 322 
significantly different (betadisper P<0.05) in all comparisons, which lent support to the statistically 323 
significant, albeit visibly weak effects of breastfeeding as reported by PERMANOVA. Samples with 324 
missing metadata (NA) for the given clinical covariate were excluded prior to running each cross-sectional 325 
analysis. Effect sizes and statistical significance were determined by 1,000 permutations, and P-values 326 
corrected for multiple testing using the Benjamini-Hochberg false discovery rate (FDR = 5%). Statistical 327 
tests of between-group taxonomic abundance comparisons (Welch’s t-test with p-values FDR-corrected) 328 
were performed in the Statistical Analysis of Metagenomics Profiles program v2.052. MaAsLin53 was used 329 
for adjustment of covariates when determining the significance of species associated with a specific 330 
variable while accounting for potentially confounding covariates, as previously described14,15. All the 331 
covariates tested in the PERMANOVA were included in the adjustment along with the sequencing depth 332 
used as fixed effects. The default MaAsLin parameters were applied (maximum percentage of samples NA 333 
in metadata 10%, minimum percentage relative abundance 0.01%, P < 0.05, q < 0.25).  334 
Bacterial isolation and whole-genome sequencing  335 
Raw faecal samples from neonates stored in the biobank lab at -80°C were requested based on faecal 336 
carriage of targeted species over 1% relative abundance in metagenomes. Selected frozen faecal aliquots, 337 
where available (> 100 ng) were couriered on dry ice to the Wellcome Sanger Institute within 6 hours of 338 
shipment from the biobank lab. Bacterial isolates were cultured using the following culture media: 339 
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Enterococcus faecium ChromoSelect Agar Base (Sigma-Aldrich) for Enterococcus spp., CP ChromoSelect 340 
Agar (Sigma-Aldrich) for Closteridium spp., Coliform ChromoSelect Agar (Sigma-Aldrich) and Klebsiella 341 
ChromoSelect Selective Agar (Sigma-Aldrich) for species of Enterobacteriaceae. Between 2-5 colonies 342 
per sample were picked for full-length 16S rRNA gene sequencing to confirm species identification, as 343 
described previously54. Bacterial isolates with species identification congruent with metagenomic 344 
identification were re-streaked and purified for genomic DNA extraction using DNeasy 96 kit. DNA 345 
sequencing was performed on the Illumina HiSeq X, generating paired-end reads (2 x 151bp). Multiple 346 
strains per species per faecal sample were also sequenced based on variation across the full-length 16S 347 
rRNA sequences. Bacterial genomes were assembled and annotated using the pipeline described 348 
previously55. Genome assemblies were subjected to quality check and contaminant screening with 349 
CheckM56 and Mash57, respectively. Where applicable, the suspected contaminant (non-target organism) 350 
sequences were confirmed and filtered out via raw read mapping using Bowtie2 v2.3.0, prior to re-351 
assembly.  352 
Bacterial phylogenetic analysis  353 
The phylogenetic analysis of the complete diverse species collection was conducted by extracting the amino 354 
acid sequence of 40 universal core marker genes58,59 from the BBS bacterial culture collection using 355 
SpecI60. The protein sequences were concatenated and aligned with MAFFT v.7.2040, and maximum-356 
likelihood trees were constructed using RAxML47 with default settings. Four most prevalent BBS collection 357 
opportunistic pathogen species E. faecalis, E. cloacae, K. oxytoca and K. pneumoniae were further analysed 358 
in context of the public genomes (Supplementary Table 10), including the UK hospital strain collections29-359 
32, the gut microbiota-cultured strains from the HGG and the Culturable Genome Reference (CGR)61 360 
collections, and the environmental strains on the Genome Taxonomy Database (GTDB, v86) 62. To generate 361 
phylogenetic trees of individual species, the public genome assemblies were combined with the assemblies 362 
of the study isolates, annotated with Prokka63, and a pangenome estimated using Roary64. Where multiple 363 
identical strains (no SNP difference in species core-genome) were cultured from the same faecal sample, 364 
only one representative strain was included in the species phylogenetic trees. A 95% identity cut-off was 365 
used, and core genes were defined as those in 99% of isolates unless otherwise stated. A maximum 366 
likelihood tree of the SNPs in the core genes was created using RAxML47 and 100 bootstraps. To illustrate 367 
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the population structure of the closely related Enterobacter and Klebsiella strain isolates, FastANI65 was 368 
used to estimate the pairwise average nucleotide identity distance between all public and BBS genome 369 
assemblies, which was then used as an input to generate a neighbour-joining with BIONJ66. All 370 
phylogenetic trees were visualised in iTOL67. Sequence types were determined using MLSTcheck68, which 371 
was used to compare the assembled genomes against the MLST database for the corresponding species.  372 
Detecting virulence and resistance genes  373 
ABRicate (v0.8.13, https://github.com/tseemann/abricate) was used to screen for known, acquired 374 
resistance genes and virulence factors against bacterial genome assemblies. For AMR genes, a 375 
comprehensive BLAST database integrating 5,556 non-redundant sequences in the NCBI Bacterial 376 
Antimicrobial Resistance Reference Gene Database (PRJNA313047), CARD v2.0.3, ARG-ANNOT and 377 
ResFinder was queried against. 3,202 non-redundant experimentally validated core virulence genes in 378 
VFDB (version 5 Oct 2018) were included to build a BLAST database for virulence factor screening.  379 
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